ESWI invites coalition partners: Life Course Immunisation: A Seamless Approach to Protection Across All Ages
Mon 20 Oct 2025, 11:30-13:00, Auditorium 3 - Breakout, Valencia
Stefania MAGGI, ESWI Board Member, National Research Council of Italy, Italy
Catherine WEIL OLIVIER, independent expert, Trustee of CLCI, France
Paula TÄHTINEN, ESWI Board Member, Turku University Hospital and University of Turku, Finland
Nicola VERONESE, Unicamillus University, Italy
Catherine MOORE, Public Health Wales, United Kingdom
George KASSIANOS, ESWI Board Member, United Kingdom
Lars-Åke SÖDERLUND, International Pharmaceutical Federation, Sweden
Featuring:
Honorary Professor of Paediatrics, Paris VII University, France
Catherine is a distinguished member of the CLCI board who brings a wealth of knowledge and experience in paediatrics and vaccinology. She earned her medical degree in Paris and has been a Professor of Paediatrics at Paris VII University since 1989.
From 1995 to 2005, she held the prestigious position of Head of the Department of General Paediatrics at Assistance Publique Hôpitaux de Paris. Her expertise has been sought in various capacities over the last two decades. This includes serving as an expert for the French Drug Agency (AFSSAPS, now ANSM), where she worked in the technical group to register vaccines, antibiotics, and anti-virals, a Core Member of the European Medicines Agency Vaccine Working Party, a valued member of European Centre for Control and Prevention (ECDC) working groups, Infovac France and several French paediatric groups. Her involvement with French health policy extends to being a member of the national French Technical Committee on Vaccination and the National Committee against Influenza.
Nationality: Italian
Position: Research Director, CNR Ageing Branch, Neuroscience Institute, Padova (Italy)
Research Fields: Clinical epidemiology and geriatrics. Main focus on lifelong approach to healthy ageing
ESWI member since 2022
Dr. Stefania Maggi received her degree in Medicine and Surgery from the University of Padua, Italy in 1983. She also attended the Graduate School of Geriatrics and Gerontology from the same University until 1987 and in 1988 she received her Master in Public Health from John Hopkins University in Baltimore (USA). Dr. Maggi also holds a PhD in Clinical Pathophysiology from the University of Padua, which she received in 2000.
Dr. Maggi has a specific interest in the epidemiology of ageing and in the analysis of factors promoting health ageing in a lifelong approach. From 1983-1985, Dr. Maggi worked as an attending physician at the Internal Medicine Department for the University Hospital in Padua before she spent the years of 1988-1989 as a postdoctoral fellow at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), for the National Institute of Health (NIH) in Bethesda, Maryland (USA). From 1989-1993, she worked as the Coordinator for the WHO Program on Ageing, before she moved on to work as a researcher in the Ageing branch at the Institute of Neuroscience, Consiglio Nazionale Delle Ricerche (CNR), Padua. Dr. Maggi worked as a researcher from 1993-2007 before becoming Research Director for the same branch and institute, in 2007, a position she currently holds. In this position, she coordinates several national and international research projects on nutrition, vaccines and lifestyle as key factors for promoting healthy ageing. Dr. Maggi is also an Adjunct Professor in the Graduate Schools of Geriatric Medicine at the University of Padua, which she has been since 2000.
Moreover, Dr. Maggi is the Editor in Chief of “Ageing Clinical and Experimental Research” (Springer) and has more than 800 publications, both in peer-reviewed journals and many book chapters.
- ESWI invites coalition partners: Life Course Immunisation: A Seamless Approach to Protection Across All Ages
- Association between vaccinations and risk of dementia: a systematic review and meta-analysis
- Burden of disease in acute respiratory virus infections
- ESWI invites coalition partners: Life Course Immunisation: A Seamless Approach to Protection Across All Ages
- RSV - the bumpy road towards a vaccine
- Will individuals need an annual COVID-19 vaccination?
- What are the risks of RSV infections for older individuals?
- ESWI Respiratory Virus Summit 2024 recap video
- Welcome By The Co-Chairs at the Respiratory Virus Summit 2024
- Burden of acute respiratory virus infections
- ESWI Respiratory Virus Summit 2024
- Communication: Raising awareness on the burden of disease
- ESWI Symposium: RSV Looking towards the future
- Burden of disease - A focus on acute respiratory viruses in older adults
- RSV looking towards the future
- Respiratory Virus Summit 2023
- A geriatrician's insight into reducing the burden of disease in older adults
Nationality: Finnish
Position: Clinical Lecturer and Adjunct Professor, Paediatrics and Adolescent Medicine, University of Turku
Research Fields: respiratory tract infections, especially acute otitis media
ESWI member since 2022
Dr. Tähtinen received her Doctor of Medicine from the University of Turku in 2004. After graduating, she worked as a GP and resident in paediatrics in Central Finland and then as a PhD student at the University of Turku. In 2012, she successfully defended her PhD thesis entitled “Treatment of acute otitis media”. The same year, she received the ESPID Young Investigator Award and was selected as a Researcher of the Year by the National Graduate School of Clinical Investigation. After obtaining her PhD degree, Dr. Tähtinen continued her specialisation in paediatrics at the Turku University Hospital, Department of Paediatrics and Adolescent Medicine.
In 2013-2015 and in 2017 Dr. Tähtinen moved to the United States to work as a Postdoctoral Research Fellow at the Boston University School of Medicine and Harvard T.H. Chan School of Public Health. During her time in Boston, Dr. Tähtinen also studied at the Harvard Medical School Global Clinical Scholars Research Training Program in which she graduated in 2015.
Currently, Paula Tähtinen is an Adjunct Professor and Clinical Lecturer at the University of Turku, Finland. She is also working as a paediatrician at Turku University Hospital. She is leading her own research group with the main focus on prevention and treatment of respiratory tract infections. Dr. Tähtinen has been actively involved in the development of scientific and professional education at the University of Turku. She has also served as a Young ESPID (European Society for Paediatric Infectious Diseases) country representative and a committee member at the ESPID Research Networking Committee. In 2022, Dr. Tähtinen received the Helena and Niilo Hallman Prize for the best young researcher in the field of paediatrics.
- Burden of disease in acute respiratory virus infections
- ESWI invites coalition partners: Life Course Immunisation: A Seamless Approach to Protection Across All Ages
- What is the difference between influenza and a common cold?
- Immunisation & Treatment - Societal benefits of immunising children
- Webinar: Immunisation & Treatment
- Respiratory tract infections in children - our paediatrician's insight and bold vision for the future
Nationality: British and Cypriot
Position: Family Physician. National Immunisation Lead Royal College of General Practitioners. President British Global & Travel Health Association.
Research Fields: Primary Care Vaccinations
Dr George Kassianos is a GP and the National Immunisation Lead of the Royal College of General Practitioners of which he is a Fellow. He is also President and Fellow of the British Global and Travel Health Association (BGTHA) and Fellow of the Faculty of Travel Medicine at the Royal College of Physicians and Surgeons Glasgow (RCPSG), the International Society of Travel Medicine (ISTM), the European Society of Cardiology (ESC), the British and Irish Hypertension Society (BIHS), The Academy of Medical Educators, and the Higher Education Academy.
Dr Kassianos is Chair of RAISE [Raise Awareness of Influenza Strategies in Europe], a Pan-European Group (20 countries) on influenza, and Board Member of the European Scientific Working Group on Influenza (ESWI). He has served as medical editor of four medical journals, currently serves on a number of editorial boards, and is Associate Editor (Primary Care) of ‘Drugs In Context’ international journal.
Dr Kassianos was the recipient of the Royal College of General Practitioners’ Foundation Council Award (2018), the most prestigious award for services to the College and General Practice.
In October 2020, Queen Elizabeth II appointed Dr Kassianos Commander of the Order of the British Empire (CBE) for his services to General Practice and Travel Medicine.
- Implementation of adult and risk groups national immunisation programmes
- Implementation of adult and risk groups national immunisation programmes
- ESWI invites coalition partners: Life Course Immunisation: A Seamless Approach to Protection Across All Ages
- Why not a 95-95-95 strategy for influenza by 2030?
- Why vaccinate from a very early age?
- The influenza landscape and vaccination coverage in older adults during theSARS-Cov-2 pandemic: data from Several European Countries and Israel
- Immunisation & Treatment - Travel preparedness and vaccinations
- Influenza Vaccines: What Does the mRNA Platform Have to Offer?
- Reaching for New Heights: Breaking Down Influenza Trends and Prevention Efforts
- Impact of General Practitioner Education on Acceptance of an Adjuvanted Seasonal Influenza Vaccine among Older Adults in England
- What COVID-19 Vaccines Can and Cannot Do: Setting Realistic Goals in the Current Pandemic
- Vaccinations to consider before, during, and after pregnancy
- Childhood Influenza Vaccination and treatment in a COVID-19 era